liver cancer

ENGAGING EXPERTS

High Economic Burden of HCC Treated With Loco-Regional Therapies

01/27/2021

Journal of Clinical Pathways

Conference Coverage

Lenvatinib Effective for Unresectable HCC in the Real-World Setting

01/16/2021

Journal of Clinical Pathways

Conference Coverage

Atezolizumab Plus Bevacizumab Unlikely to be Cost-Effective Compared With Sorafenib for HCC

01/15/2021

Journal of Clinical Pathways

News

ASCO Systemic Therapy Guideline Developed for Advanced HCC

11/25/2020

Journal of Clinical Pathways

Research in Review

Common Second-Line Treatment for Liver Cancer Deemed Not Cost-Effective

07/03/2017

JCP Editors

A conventional second-line treatment for hepatocellular carcinoma offers only a marginal increase in quality-adjusted life-years (QALYs) at a significantly high cost, according to an analysis published in Cancer...

A...

07/03/2017

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

liver cancer

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products